Literature DB >> 8026615

Hydra cell aggregate development is blocked by selective fragments of fibronectin and type IV collagen.

X Zhang1, B G Hudson, M P Sarras.   

Abstract

The Cnidarian, Hydra, is a simplified metazoan whose body wall is composed of an epithelial bilayer with an intervening extracellular matrix termed the mesoglea. Hydra mesoglea has been shown to have a number of components seen in higher invertebrate and vertebrate matrices, including fibronectin, type IV collagen, laminin, and heparan sulfate proteoglycan. Based on previous studies which indicated that extracellular matrix components are critical to hydra development, the current study was designed to determine the role of intact fibronectin and its various functional domains during development of hydra cell aggregates. Hydra cell aggregation involves the complete morphogenesis of adult hydra from pellets of dissociated hydra cells. During this development process, cells segregate into an epithelial bilayer and then deposit a new extracellular matrix prior to continuation of morphogenesis. Results from this study demonstrate that intact fibronectin and its 30-kDa gelatin binding domain are effective blockers of hydra cell aggregate development. The gelatin binding capacity of the 30-kDa fragment is lost upon reduction and in the present studies reduction and alkylation of this fragment resulted in a loss in its ability to block hydra cell aggregate development. Because of these findings and the potential for collagen interaction with the 30-kDa gelatin binding domain, studies were also performed with various type IV collagen domains. These studies indicated that both the NC1 and 7 S domains of type IV collagen were also effective blockers of hydra cell aggregate development. These results were mimicked when antibodies to fibronectin or type IV collagen were used. Structural changes in mesoglea, inhibition of cell proliferation, and changes in cell differentiation patterns accompanied the blockage of hydra cell aggregates. These results indicate that blockage may be due to alterations in mesoglea structure with accompanying effects on cell behavior. It is concluded that (i) fibronectin and type IV collagen are critical to the early stages of hydra cell aggregate development when the mesoglea is initially formed and that (ii) perturbation of aggregate development by fragments of these extracellular matrix components results in alterations in hydra cell division, cell differentiation, and morphogenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8026615     DOI: 10.1006/dbio.1994.1176

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  10 in total

Review 1.  New functional roles for non-collagenous domains of basement membrane collagens.

Authors:  Nathalie Ortega; Zena Werb
Journal:  J Cell Sci       Date:  2002-11-15       Impact factor: 5.285

2.  Characterization of a non-fibrillar-related collagen in the mollusc Haliotis tuberculata and its biological activity on human dermal fibroblasts.

Authors:  Christophe Fleury; Antoine Serpentini; Magdalini Kypriotou; Emmanuelle Renard; Philippe Galéra; Jean-Marc Lebel
Journal:  Mar Biotechnol (NY)       Date:  2011-01-27       Impact factor: 3.619

3.  Cell adhesion to extracellular matrix is different in marine hydrozoans compared with vertebrates.

Authors:  V Schmid; B Aeschbach; K Agata; J Kosaka; S Reber-Müller; N Sprenger; G Eguchi
Journal:  Rouxs Arch Dev Biol       Date:  1995-08

4.  Recombinant alpha2(IV)NC1 domain inhibits tumor cell-extracellular matrix interactions, induces cellular senescence, and inhibits tumor growth in vivo.

Authors:  Jennifer M Roth; Abebe Akalu; Anat Zelmanovich; Desiree Policarpio; Bruce Ng; Shannon MacDonald; Silvia Formenti; Leonard Liebes; Peter C Brooks
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

5.  Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin.

Authors:  Yuki Hamano; Michael Zeisberg; Hikaru Sugimoto; Julie C Lively; Yohei Maeshima; Changqing Yang; Richard O Hynes; Zena Werb; Akulapalli Sudhakar; Raghu Kalluri
Journal:  Cancer Cell       Date:  2003-06       Impact factor: 31.743

Review 6.  An intracellular trafficking pathway in the seminiferous epithelium regulating spermatogenesis: a biochemical and molecular perspective.

Authors:  C Yan Cheng; Dolores D Mruk
Journal:  Crit Rev Biochem Mol Biol       Date:  2009 Sep-Oct       Impact factor: 8.250

Review 7.  Mammalian collagen IV.

Authors:  Jamshid Khoshnoodi; Vadim Pedchenko; Billy G Hudson
Journal:  Microsc Res Tech       Date:  2008-05       Impact factor: 2.769

8.  MT2-MMP-dependent release of collagen IV NC1 domains regulates submandibular gland branching morphogenesis.

Authors:  Ivan T Rebustini; Christopher Myers; Keyonica S Lassiter; Andrew Surmak; Ludmila Szabova; Kenn Holmbeck; Vadim Pedchenko; Billy G Hudson; Matthew P Hoffman
Journal:  Dev Cell       Date:  2009-10       Impact factor: 12.270

9.  Regulation of COX-2 mediated signaling by alpha3 type IV noncollagenous domain in tumor angiogenesis.

Authors:  Chandra Shekhar Boosani; Arjuna P Mannam; Dominic Cosgrove; Rita Silva; Kairbaan M Hodivala-Dilke; Venkateshwar G Keshamouni; Akulapalli Sudhakar
Journal:  Blood       Date:  2007-04-10       Impact factor: 22.113

Review 10.  Inhibition of tumor angiogenesis by tumstatin: insights into signaling mechanisms and implications in cancer regression.

Authors:  Akulapalli Sudhakar; Chandra S Boosani
Journal:  Pharm Res       Date:  2008-06-13       Impact factor: 4.200

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.